Perbak Capital Partners »

Amneal Pharmaceuticals shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Perbak Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $362k 29k 12.43

More positions owned by Perbak Capital Partners

Select Sector Spdr Tr State Street Ind (XLI)
Select Sector Spdr Tr State Street Con (XLY)
Select Sector Spdr Tr State Street Con (XLP)
Vaneck Etf Trust Oil Services Etf (OIH)
Spdr Series Trust State Street Spd (KIE)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Real Estate Etf (VNQ)
Select Sector Spdr Tr State Street Mat (XLB)
Select Sector Spdr Tr State Street Hea (XLV)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
Ishares Tr Ishares Semicdtr (SOXX)
Draftkings Com Cl A (DKNG)
Spdr Series Trust State Street Spd (XHB)
Northrop Grumman Corporation (NOC)

View all positions for Perbak Capital Partners

Top funds holding Amneal Pharmaceuticals

BlackRock
Tpg Gp A
Vanguard Portfolio Management
Rubric Capital Management
Vanguard Capital Management
State Street Corporation
Dimensional Fund Advisors
Morgan Stanley
Geode Capital Management
Neuberger Berman Group
Nuveen
Invesco
Goldman Sachs Group
Nantahala Capital Management
Allspring Global Investments Holdings

View all funds holding Amneal Pharmaceuticals